Safety trial of ECI301 for hepatocellular carcinoma patient treated with radio frequency ablatio
Not Applicable
- Conditions
- Hepatocellular carcinoma patinets
- Registration Number
- JPRN-UMIN000020798
- Lead Sponsor
- Kanazawa University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have severe disease in heart, kidnet, lung, hematopoiesis, coagulation system are excluded. Peatients who undego surgery, TACE, chmotherapy and radiation therapy within 4 weeks before the entry are excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method